Population (N = 365) | Intracranial lesion (N = 26) | No intracranial lesion (N = 339) | p-value | |
---|---|---|---|---|
Age (years, SD) | 86.5 (8.5) | 86.8 (8.6) | 86.4 (8.5) | 0.80 |
Age < 75 (n, %) | 41 (11.2) | 2 (7.7) | 39 (11.5) | |
Age ≥ 75 (n, %) | 324 (88.8) | 24 (92.3) | 300 (88.5) | 0.55 |
Gender, female (n, %) | 244 (66.8) | 22 (84.6) | 222 (65.5) | 0.05 |
Residence (n, %) | ||||
Nursing home | 144 (39.5) | 10 (38.5) | 134 (39.5) | 0.92 |
Home, with relatives | 115 (31.5) | 9 (34.6) | 106 (31.3) | 0.72 |
Home, alone | 106 (29.0) | 7 (26.9) | 99 (29.2) | 0.81 |
Antiplatelets (n, %) | ||||
Aspirin | 112 (30.7) | 11 (42.3) | 101 (29.8) | 0.18 |
Clopidogrel | 27 (7.4) | 1 (3.8) | 26 (7.7) | 0.40 |
Aspirin + Clopidogrel | 2 (0.55) | 0 (0) | 2 (0.59) | 0.86 |
Anticoagulant (n, %) | ||||
Warfarin | 60 (16.4) | 5 (19.2) | 55 (16.2) | 0.69 |
Direct oral anticoagulant | 61 (16.7) | 3 (11.5) | 58 (17.1) | 0.34 |
Subcutaneous anticoagulant | 7 (1.9) | 1 (3.8) | 6 (1.8) | 0.40 |
Psychoactive drug (n, %) | ||||
Benzodiazepine | 100 (27.4) | 10 (38.4) | 90 (26.5) | 0.19 |
Antidepressant | 65 (17.8) | 8 (30.8) | 57 (16.8) | 0.07 |
Neuroleptic | 18 (4.9) | 0 (0.0) | 18 (5.3) | 0.25 |
Antiepileptic | 11 (3.0) | 0 (0.0) | 11 (3.2) | 0.43 |
History | ||||
Cognitive impairment (n, %) | 126 (34.5) | 9 (34.6) | 117 (34.5) | 0.99 |
Clinical Frailty Scale (mean, SD) | 4.6 (1.6) | 4.9 (1.7) | 4.6 (1.6) | 0.33 |
Neurosurgical intervention | 10 (2.7) | 0 (0.0) | 10 (2.9) | 0.47 |